TY - JOUR
KW - Rifampicin
KW - Buruli ulcer
AU - Jansson M
AU - Beissner M
AU - Phillips RO
AU - Badziklou K
AU - Piten E
AU - Maman I
AU - Sarfo FS
AU - Huber KL
AU - Rhomberg A
AU - Symank D
AU - Wagner M
AU - Wiedemann FX
AU - Nitschke J
AU - Kere AB
AU - Herbinger K
AU - Adjei O
AU - Löscher T
AU - Bretzel G
AB - <p>This study evaluates a novel assay to detect rifampicin resistance in clinical Mycobacterium ulcerans isolates. Although highly susceptible for PCR inhibitors in 50% of samples tested, the assay was 100% M. ulcerans-specific and yielded &gt;98% analyzable sequences with a lower limit of detection of 100-200 copies of the target sequence.</p>

BT - Journal of clinical microbiology
C1 - <p>http://www.ncbi.nlm.nih.gov/pubmed/24478404?dopt=Abstract</p>

DA - 2014 Jan 29
DO - 10.1128/JCM.03119-13
J2 - J. Clin. Microbiol.
LA - eng
N2 - <p>This study evaluates a novel assay to detect rifampicin resistance in clinical Mycobacterium ulcerans isolates. Although highly susceptible for PCR inhibitors in 50% of samples tested, the assay was 100% M. ulcerans-specific and yielded &gt;98% analyzable sequences with a lower limit of detection of 100-200 copies of the target sequence.</p>

PY - 2014
T2 - Journal of clinical microbiology
TI - Molecular determination of Rifampicin resistance in clinical samples of patients with buruli ulcer disease: A comparison of two assays.
UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993512/pdf/zjm1246.pdf
SN - 1098-660X
ER -